Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

839 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Enzalutamide versus abiraterone as a first-line endocrine therapy for castration-resistant prostate cancer (ENABLE study for PCa): a study protocol for a multicenter randomized phase III trial.
Izumi K, Mizokami A, Namiki M, Inoue S, Tanaka N, Yoshio Y, Ishibashi K, Kamiyama M, Kawai N, Enokida H, Shima T, Takahara S. Izumi K, et al. Among authors: namiki m. BMC Cancer. 2017 Oct 10;17(1):677. doi: 10.1186/s12885-017-3661-2. BMC Cancer. 2017. PMID: 29017493 Free PMC article. Clinical Trial.
[Update of treatment for prostate cancer].
Namiki M, Mizokami A, Kitagawa I. Namiki M, et al. Gan To Kagaku Ryoho. 2013 Jan;40(1):47-51. Gan To Kagaku Ryoho. 2013. PMID: 23463896 Japanese. No abstract available.
Nadir prostate-specific antigen (PSA) level and time to PSA nadir following primary androgen deprivation therapy as independent prognostic factors in a Japanese large-scale prospective cohort study (J-CaP).
Kitagawa Y, Ueno S, Izumi K, Mizokami A, Hinotsu S, Akaza H, Namiki M. Kitagawa Y, et al. Among authors: namiki m. J Cancer Res Clin Oncol. 2014 Apr;140(4):673-9. doi: 10.1007/s00432-014-1612-8. Epub 2014 Feb 13. J Cancer Res Clin Oncol. 2014. PMID: 24522405
Optimal treatment for castration-resistant prostate cancer.
Izumi K, Namiki M. Izumi K, et al. Among authors: namiki m. Asian J Androl. 2014 May-Jun;16(3):498. doi: 10.4103/1008-682X.126380. Asian J Androl. 2014. PMID: 24759581 Free PMC article. No abstract available.
[Mechanisms of prostate cancer recurrence].
Mizokami A, Namiki M. Mizokami A, et al. Among authors: namiki m. Hinyokika Kiyo. 2002 Nov;48(11):709-11. Hinyokika Kiyo. 2002. PMID: 12512146 Free article. Japanese.
839 results